DK572887A - Estere af hexahydro-8-hydroxy-2,6-methan-2h-quinolizin(on)er farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf deres fremstilling - Google Patents

Estere af hexahydro-8-hydroxy-2,6-methan-2h-quinolizin(on)er farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf deres fremstilling

Info

Publication number: DK572887A
Authority: DK; Denmark
Prior art keywords: quinolizin; methan; hexahydro; hydroxy; esters
Prior art date: 1986-11-03

Application number

DK572887A

Other languages

English (en)

Other versions

DK572887D0 (da

DK171116B1 (da

Inventor

Maurice Ward Gittos

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-11-03

Filing date

1987-11-02

Publication date

1988-05-04

1987-11-02 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1987-11-02 Publication of DK572887D0 publication Critical patent/DK572887D0/da

1988-05-04 Publication of DK572887A publication Critical patent/DK572887A/da

1996-06-17 Application granted granted Critical

1996-06-17 Publication of DK171116B1 publication Critical patent/DK171116B1/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK572887A 1986-11-03 1987-11-02 Estere af hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-oner og hexahydro-8-hydroxy-2,6-methano-2H-quinoliziner og farmaceutisk acceptable syreadditionssalte og kvaternære ammoniumsalte deraf, fremgangsmåde til deres fremstilling samt et mellemprodukt DK171116B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US92661986A	1986-11-03	1986-11-03
US92661986		1986-11-03

Publications (3)

Publication Number	Publication Date
DK572887D0 DK572887D0 (da)	1987-11-02
DK572887A true DK572887A (da)	1988-05-04
DK171116B1 DK171116B1 (da)	1996-06-17

Family

ID=25453460

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK572887A DK171116B1 (da)	1986-11-03	1987-11-02	Estere af hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-oner og hexahydro-8-hydroxy-2,6-methano-2H-quinoliziner og farmaceutisk acceptable syreadditionssalte og kvaternære ammoniumsalte deraf, fremgangsmåde til deres fremstilling samt et mellemprodukt

Country Status (21)

Country	Link
EP (1)	EP0266730B1 (da)
JP (2)	JP2542225B2 (da)
KR (1)	KR950011737B1 (da)
CN (1)	CN1021654C (da)
AR (1)	AR246264A1 (da)
AT (1)	ATE109779T1 (da)
AU (1)	AU600318B2 (da)
CA (1)	CA1329203C (da)
DE (2)	DE3750359T2 (da)
DK (1)	DK171116B1 (da)
ES (1)	ES2061469T3 (da)
FI (1)	FI87786C (da)
HU (1)	HU197008B (da)
IE (1)	IE63670B1 (da)
IL (1)	IL84309A (da)
NL (1)	NL970043I2 (da)
NO (2)	NO165922C (da)
NZ (1)	NZ222349A (da)
PH (2)	PH24664A (da)
PT (1)	PT86060B (da)
ZA (1)	ZA878096B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0329902A1 (en) *	1988-02-23	1989-08-30	Merrell Dow Pharmaceuticals Inc.	Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of psychosis
US5011846A (en) *	1988-02-23	1991-04-30	Merrell Dow Pharmaceuticals Inc.	Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
EP0329904A1 (en) *	1988-02-23	1989-08-30	Merrell Dow Pharmaceuticals Inc.	Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of anxiety
EP0329903A1 (en) *	1988-02-23	1989-08-30	Merrell Dow Pharmaceuticals Inc.	Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of glaucoma
EP0329932B1 (en) *	1988-02-23	1995-10-18	Merrell Pharmaceuticals Inc.	Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments
EP0329905A1 (en) *	1988-02-23	1989-08-30	Merrell Dow Pharmaceuticals Inc.	Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for increasing gastric motility
EP0330788A1 (en) *	1988-03-01	1989-09-06	Merrell Dow Pharmaceuticals Inc.	Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia
ZA893008B (en) *	1988-04-29	1989-12-27	Merrell Dow Pharma	Process for preparing indole-3-carboxylic acid esters of transhexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one
GB8928837D0 (en) *	1989-12-21	1990-02-28	Beecham Group Plc	Pharmaceuticals
EP0492020A1 (en) *	1990-12-21	1992-07-01	Merrell Dow Pharmaceuticals Inc.	Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
HUP0100142A3 (en) *	1997-12-17	2002-01-28	Biocryst Pharmaceuticals Inc B	Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
CN100390172C (zh) *	2004-09-10	2008-05-28	成都欣捷高新技术开发有限公司	一种甲磺酸多拉司琼晶型及其制备方法
WO2006056081A1 (de) *	2004-11-25	2006-06-01	Cilag Ltd.	Verfahren zur herstellung von estern von hexahydro-8-hydroxy-2,6-methano-2h-chinolizin-3(4h)-on
ATE411314T1 (de) *	2005-07-06	2008-10-15	Inke Sa	Verfahren zur gewinnung der pharmazeutisch aktiven verbindung dolasetron, synthese- zwischenprodukte davon und verfahren zu deren gewinnung
ES2264901B1 (es)	2005-07-06	2007-12-01	Inke, S.A.	Procedimiento para la obtencion de un compuesto farmaceuticamente activo, sus intermedios de sintesis y procedimiento para la obtencion de los mismos.
WO2007081890A2 (en) *	2006-01-05	2007-07-19	Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság	Production of dolasetron
EP2060557B1 (en)	2007-11-13	2012-06-06	Inke, S.A.	Intermediate compounds useful to prepare dolasetron
ES2432618T3 (es)	2009-05-20	2013-12-04	Inserm (Institut National De La Santé Et De La Recherche Medicale)	Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
SI2432467T1 (en)	2009-05-20	2018-06-29	Inserm (Institut National De La Sante Et De La Recherche Medicale)	ANTAGONIST RECEPTOR SEROTONINA 5-HT3 FOR THE USE IN THE TREATMENT OF LEASE VESTIBULAR DISEASES
EP4019018A1 (en)	2015-09-11	2022-06-29	Chase Pharmaceuticals Corporation	Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
CN108976230A (zh) *	2018-06-18	2018-12-11	东莞市联洲知识产权运营管理有限公司	一种基于石墨烯活化制备甲磺酸多拉司琼关键中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2531083B1 (fr) *	1982-06-29	1986-11-28	Sandoz Sa	Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
CH664567A5 (de) *	1983-08-26	1988-03-15	Sandoz Ag	Aromatische carbonsaeure- und sulfonsaeureester oder -amide.
ATE86110T1 (de) *	1984-12-20	1993-03-15	Sandoz Ag	Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten.

1987
- 1987-10-28 ZA ZA878096A patent/ZA878096B/xx unknown
- 1987-10-29 CA CA000550612A patent/CA1329203C/en not_active Expired - Lifetime
- 1987-10-29 NZ NZ222349A patent/NZ222349A/xx unknown
- 1987-10-29 IL IL84309A patent/IL84309A/xx not_active IP Right Cessation
- 1987-10-29 FI FI874768A patent/FI87786C/fi not_active IP Right Cessation
- 1987-10-30 AR AR87309166A patent/AR246264A1/es active
- 1987-10-30 PH PH36006A patent/PH24664A/en unknown
- 1987-11-02 NO NO874550A patent/NO165922C/no not_active IP Right Cessation
- 1987-11-02 DE DE3750359T patent/DE3750359T2/de not_active Expired - Lifetime
- 1987-11-02 AT AT87116119T patent/ATE109779T1/de not_active IP Right Cessation
- 1987-11-02 JP JP62275894A patent/JP2542225B2/ja not_active Expired - Lifetime
- 1987-11-02 IE IE295587A patent/IE63670B1/en not_active IP Right Cessation
- 1987-11-02 DE DE1997175092 patent/DE19775092I2/de active Active
- 1987-11-02 CN CN87107629A patent/CN1021654C/zh not_active Expired - Lifetime
- 1987-11-02 PT PT86060A patent/PT86060B/pt unknown
- 1987-11-02 EP EP87116119A patent/EP0266730B1/en not_active Expired - Lifetime
- 1987-11-02 HU HU874918A patent/HU197008B/hu unknown
- 1987-11-02 AU AU80596/87A patent/AU600318B2/en not_active Expired
- 1987-11-02 ES ES87116119T patent/ES2061469T3/es not_active Expired - Lifetime
- 1987-11-02 DK DK572887A patent/DK171116B1/da not_active IP Right Cessation
- 1987-11-03 KR KR1019870012286A patent/KR950011737B1/ko not_active IP Right Cessation
1990
- 1990-01-02 PH PH39830A patent/PH26261A/en unknown
1996
- 1996-02-27 JP JP8065408A patent/JP2657267B2/ja not_active Expired - Lifetime
1997
- 1997-12-17 NL NL970043C patent/NL970043I2/nl unknown
1999
- 1999-08-26 NO NO1999020C patent/NO1999020I1/no unknown

Also Published As

Publication number	Publication date
ZA878096B (en)	1988-04-26
HU197008B (en)	1989-02-28
JPS63258476A (ja)	1988-10-25
AR246264A1 (es)	1994-07-29
IL84309A (en)	1991-09-16
ES2061469T3 (es)	1994-12-16
NO165922C (no)	1991-05-02
DE19775092I2 (de)	2001-11-22
FI87786B (fi)	1992-11-13
JP2657267B2 (ja)	1997-09-24
NL970043I2 (nl)	1998-10-01
FI874768A (fi)	1988-05-04
PH24664A (en)	1990-09-07
CN1021654C (zh)	1993-07-21
NZ222349A (en)	1990-05-28
DE3750359D1 (de)	1994-09-15
PT86060B (pt)	1990-07-31
EP0266730A1 (en)	1988-05-11
HUT45055A (en)	1988-05-30
IE63670B1 (en)	1995-05-31
AU8059687A (en)	1988-05-05
AU600318B2 (en)	1990-08-09
KR880006240A (ko)	1988-07-22
KR950011737B1 (ko)	1995-10-09
NO874550L (no)	1988-05-04
PH26261A (en)	1992-04-01
JPH0977769A (ja)	1997-03-25
NL970043I1 (nl)	1998-03-02
PT86060A (en)	1987-12-01
JP2542225B2 (ja)	1996-10-09
IE872955L (en)	1988-05-03
DK572887D0 (da)	1987-11-02
CA1329203C (en)	1994-05-03
CN87107629A (zh)	1988-06-15
NO165922B (no)	1991-01-21
DK171116B1 (da)	1996-06-17
NO1999020I1 (no)	1999-08-26
DE3750359T2 (de)	1994-12-08
FI874768A0 (fi)	1987-10-29
ATE109779T1 (de)	1994-08-15
EP0266730B1 (en)	1994-08-10
NO874550D0 (no)	1987-11-02
FI87786C (fi)	1993-02-25

Similar Documents

Publication	Publication Date	Title
DK572887D0 (da)	1987-11-02	Estere af hexahydro-8-hydroxy-2,6-methan-2h-quinolizin(on)er farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf deres fremstilling
DK451887D0 (da)	1987-08-28	Aryloxycarboxylsyrederivater, deres fremstilling og anvendelse
DK164287D0 (da)	1987-03-31	Quinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf og deres anvendelse
DK10287A (da)	1987-07-12	Fremstilling af 2-oxo-1,3-dioxolaner og deres anvendelse
DK554187D0 (da)	1987-10-22	Fedtsyreestere af polyglycerinpolyglycolethere, deres fremstilling og deres anvendelse
NO892745D0 (no)	1989-07-03	Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling.
DK374289A (da)	1990-01-30	Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse
DK285685D0 (da)	1985-06-24	Farmaceutisk aktive derivater af d,l-glutaminsyre og d,l-asparaginsyre og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
NO871526L (no)	1987-10-19	Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling.
NO875432L (no)	1988-06-30	Sialinsyrederivater og fremgangsmaate for deres fremstilling.
DK266486A (da)	1986-12-08	Quinoloncarboxylsyreestere eller farmaceutisk anvendelige hydratereller syreadditionssalte deraf, deres fremstilling og anvendelse
NO880811D0 (no)	1988-02-24	Krystalliserte cefem-syreaddisjonssalter og fremgangsmaate til deres fremstilling.
DK23687D0 (da)	1987-01-16	Substituerede 4-amino-3-hydroxysmoersyrederivater og deres fremstilling
DK157387D0 (da)	1987-03-27	Substiturede 4-amino-3-hydroxysmoersyrederivater ogfysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK587689D0 (da)	1989-11-22	2-azabicyclo(2,2,1)hept-5-en-2-eddikesyre og derivater deraf, deres fremstilling og anvendelse
DK300488D0 (da)	1988-06-02	Mono- og polyhydroxyacylderivater af polyoxygenerede labdaner, deres fremstilling og anvendelse
DK300583D0 (da)	1983-06-29	Racemiske eller optisk aktive eburnanoximderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
DK299983A (da)	1983-12-31	Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse
DK284789A (da)	1989-12-11	Fremgangsmaade til fremstilling af n-(23-vinblastinoyl)-derivater af 1-aminomethylphosphonsyre
DK30586D0 (da)	1986-01-21	N-substituerede 2-chlor-7-fluor-10-piperzino-10,11-dihydrodibenzo(b,f)thiepiner, deres syreadditionssalte og fremgangsmaader til deres fremstilling
DK161702C (da)	1992-01-13	N-(2-phenoxyethyl)nicotinamid-derivater, deres fremstilling, fungicide midler indeholdende derivaterne, samt anvendelse af derivaterne og midlerne
DK148385D0 (da)	1985-04-01	Racemiske og optisk aktive 14-hydroxyimino-eburnanderivater eller syreadditionssalte deraf og fremgangsmaade til deres fremstilling
DK554688D0 (da)	1988-10-04	Farmaceutisk aktive derivater af (r)-5-pentyl-amino-5-oxopentansyre og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK202986D0 (da)	1986-05-02	Permethrinsyre-(triazolyl-alkyl)-estere, deres fremstilling og anvendelse
DK247484A (da)	1984-11-21	Optisk aktive propionsyre-derivater, deres fremstilling og anvendelse

Legal Events

Date	Code	Title	Description
1996-06-17	B1	Patent granted (law 1993)
2000-10-30	CTFF	Application for supplementary protection certificate (spc) filed	Spc suppl protection certif: CA 1998 00008 Filing date: 19980218 Extension date: 20110926
2006-07-31	CTFG	Supplementary protection certificate (spc) issued	Free format text: PRODUCT NAME: DOLASETRONMESILAT Spc suppl protection certif: CA 1998 00008
2007-11-19	PUP	Patent expired